Critical care department, Huishan 3rd people's hospital of Wuxi city, Wuxi, P.R. China.
Science and Technology Division, Aerospace Medical & Healthcare Technology Group Co., LTD., Beijing, P.R. China.
Medicine (Baltimore). 2023 Jul 21;102(29):e33967. doi: 10.1097/MD.0000000000033967.
This study evaluated the association and prognostic significance of the systemic inflammation response index (SIRI) with mortality in sepsis. In this cohort study, the sepsis patients were retrieved from the Medical Information Mart for Intensive Care III (MIMIC-III) and MIMIC-IV intensive care unit (ICU) databases. SIRI was calculated by using the neutrophil, monocyte, and lymphocyte counts. The outcomes were 28-day mortality, 1-year mortality, and 28 days to 1-year mortality. The Cox proportional hazards model with a hazard ratio (HR) and a 95% confidence interval (CI) was used to investigate the association and prognostic value of SIRI with mortality in sepsis. Subgroup analyses of the associations of SIRI with 28-day and 1-year mortality in sepsis were based on age, gender, Simplified Acute Physiology Score II (SAPSII), Sequential Organ Failure Assessment (SOFA), and presence or absence of septic shock. The receiver operating characteristic (ROC) curve was used to compare the predictive performances of SIRI, SOFA and SAPS II for mortality in sepsis. Of the 4239 patients included, 1339 patients suffered from 28-day mortality, 2085 patients suffering from 1-year mortality, and 746 (25.72%) suffered from 28 days to 1-year mortality. High SIRI levels exhibited higher risks of 28-day mortality (HR: 1.15, 95% CI: 1.03-1.29, P = .010), 1-year mortality (HR: 1.14, 95% CI: 1.04-1.24, P = .003), and 28 days to 1-year mortality (HR: 1.16, 95% CI: 1.01-1.35, P = .047) in sepsis. A higher SIRI was reported related to 28-day mortality and 1-year mortality in sepsis patients with female gender, with SOFA < 8, with SAPS II < 44, and in sepsis patients without sepsis shock. The AUC of SIRS, SOFA, and SAPS II in predicting 28-day mortality in sepsis were 0.726, 0.591, and 0.644, respectively. The AUC of SIRI in predicting 1-year mortality in sepsis was 0.761, higher than the AUC values of SOFA and SAPS II. A higher AUC value of SIRI compared with SOFA, and SAPS II in predicting 28 days to 1-year mortality was observed. Elevated SIRI was associated with an increased risk of mortality in sepsis. SIRI is an independent prognostic biomarker of mortality in sepsis.
本研究评估了全身炎症反应指数(SIRI)与脓毒症患者死亡率之间的关联和预后意义。在这项队列研究中,从 Medical Information Mart for Intensive Care III (MIMIC-III) 和 MIMIC-IV 重症监护病房(ICU)数据库中检索到脓毒症患者。SIRI 通过使用中性粒细胞、单核细胞和淋巴细胞计数来计算。结果为 28 天死亡率、1 年死亡率和 28 天至 1 年死亡率。使用风险比(HR)和 95%置信区间(CI)的 Cox 比例风险模型来研究 SIRI 与脓毒症患者死亡率之间的关联和预后价值。SIRI 与脓毒症 28 天和 1 年死亡率相关性的亚组分析基于年龄、性别、简化急性生理学评分 II(SAPS II)、序贯器官衰竭评估(SOFA)以及是否存在或不存在脓毒性休克。受试者工作特征(ROC)曲线用于比较 SIRI、SOFA 和 SAPS II 对脓毒症患者死亡率的预测性能。在纳入的 4239 例患者中,有 1339 例患者发生 28 天死亡率,2085 例患者发生 1 年死亡率,746 例(25.72%)发生 28 天至 1 年死亡率。高 SIRI 水平与脓毒症患者 28 天死亡率(HR:1.15,95%CI:1.03-1.29,P =.010)、1 年死亡率(HR:1.14,95%CI:1.04-1.24,P =.003)和 28 天至 1 年死亡率(HR:1.16,95%CI:1.01-1.35,P =.047)风险升高相关。在女性、SOFA < 8、SAPS II < 44 的脓毒症患者中,以及在没有脓毒性休克的脓毒症患者中,较高的 SIRI 与 28 天死亡率和 1 年死亡率相关。SIRS、SOFA 和 SAPS II 在预测脓毒症患者 28 天死亡率方面的 AUC 分别为 0.726、0.591 和 0.644。SIRI 在预测脓毒症患者 1 年死亡率方面的 AUC 为 0.761,高于 SOFA 和 SAPS II 的 AUC 值。SIRI 在预测 28 天至 1 年死亡率方面的 AUC 值高于 SOFA 和 SAPS II。SIRI 升高与脓毒症患者死亡率升高相关。SIRI 是脓毒症患者死亡率的独立预后生物标志物。